Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type II diabetes: The Augsburg Diabetes Family Study

Abstract

Cross-sectional data often fail to show beneficial effects of antihypertensive therapy in patients with hypertension. We, therefore, examined the influence of hypertension control on left ventricular (LV) structure in diabetic persons separated into those having and not having any known cardiovascular disease (CVD) symptoms. The study population consisted of 394 subjects with type II diabetes. According to the presence of CVD, subjects were classified as symptomatic (N=181) or asymptomatic (N=213). In addition, three groups were differentiated: controlled hypertensives (CHs), that is, known hypertension with normal blood pressure (BP), uncontrolled hypertensives (UHs), that is, elevated BP regardless of antihypertensive medication, and normotensives (Ns). Symptomatic subjects showed a significantly higher prevalence of LV hypertrophy (LVH) (34.5 vs 23.4%, P<0.02). In contrast to symptomatic subjects where hypertension control status had no further significant impact on LV geometry, a considerable impact on preservation of normal LV geometry was observed in asymptomatic persons (LVH of 30, 15 and 18% in UH, CH and N, respectively, P<0.001). Control of hypertension in early diabetes seems especially to prevent the development of concentric hypertrophy (24 vs 11% in UH vs CH, P<0.04). In conclusion, in subjects with diabetes and CVD, the prevalence of LV structural abnormalities is very high. Although in this population-based study setting, in the latter group BP control does not seem to positively influence LV mass and function, hypertension control in still asymptomatic diabetic persons is beneficial and has a considerable impact on preservation of normal LV geometry.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Butler RA, MacDonald TM, Struthers AD, Morris AD . The clinical implications of diabetic heart disease. Eur Heart J 1998; 19: 1617–1627.

    Article  CAS  Google Scholar 

  2. Garcia MJ, McNamara PM, Gordon T, Kannel WB . Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105–111.

    Article  CAS  Google Scholar 

  3. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T . Left ventricular mass in diabetes–-hypertension. Arch Intern Med 1992; 152: 1001–1004.

    Article  CAS  Google Scholar 

  4. Francis GS . Diabetic cardiomyopathy: fact or fiction? Heart 2001; 85: 247–248.

    Article  CAS  Google Scholar 

  5. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY et al. Impact of type II diabetes on left ventricular geometry, and systolic function in hypertensive subjects. The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation 2001; 103: 102–107.

    Article  CAS  Google Scholar 

  6. Nicolino A, Longobardi G, Furgi G, Rossi M, Zoccolillo N, Ferrara N et al. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 1995; 8: 382–389.

    Article  CAS  Google Scholar 

  7. Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001; 87: 1260–1265.

    Article  CAS  Google Scholar 

  8. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH . Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.

    Article  CAS  Google Scholar 

  9. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. Am Coll Cardiol 1995; 25: 871–878.

    Article  CAS  Google Scholar 

  10. Krumholz HM, Larson M, Levy D . Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879–884.

    Article  CAS  Google Scholar 

  11. Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K . Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Am J Hypertens 2005; 18: 23–29.

    Article  Google Scholar 

  12. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–713.

    Article  Google Scholar 

  13. Mogensen CE . Combined high blood pressure and glucose in type 2 diabetes. Double jeopardy. BMJ 1998; 317: 693–694.

    Article  CAS  Google Scholar 

  14. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713–720.

    Article  Google Scholar 

  15. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Menard J, et al. for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.

    Article  CAS  Google Scholar 

  16. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW . The effect of nisoldipine as compared to enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645–652.

    Article  CAS  Google Scholar 

  17. Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JC . Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykjavik Study. J Hum Hypertens 2004; 18: 615–622.

    Article  CAS  Google Scholar 

  18. Koro CE, Bowlin SJ, Weiss S . Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients. An independent effect or confounding by indication. Pharmacoepidemiol Drug Saf 2005; 14: 697–703.

    Article  CAS  Google Scholar 

  19. McMahon AD . Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Safety 2003; 12: 551–558.

    Article  Google Scholar 

  20. Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H . Sex differences in risk factors for incident type 2 diabetes. The MONICA Augsburg Cohort Study. Arch Intern Med 2002; 162: 82–89.

    Article  Google Scholar 

  21. Hense HW, Gneiting B, Muscholl M, Broeckel U, Kuch B, Döring A et al. The associations of body size and body composition with left ventricular mass: Impacts for indexation in adults. J Am Coll Cardiol 1998; 32: 451–457.

    Article  CAS  Google Scholar 

  22. Kuch B, Hense HW, Gneiting B, Döring, A, Muscholl M et al. Body composition and prevalence of left ventricular hypertrophy. Circulation 2000; 102: 405–410.

    Article  CAS  Google Scholar 

  23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.

    Article  CAS  Google Scholar 

  24. Schunkert H, Hense HW, Muscholl M, Luchner A, Kurzinger S, Danser AH et al. Associations between circulating components of the renin–angiotensin–aldosterone system and left ventricular mass. Heart 1997; 77: 24–31.

    Article  CAS  Google Scholar 

  25. Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ et al. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the Cardiovascular Health Study. Am Heart J 1997; 133: 36–43.

    Article  CAS  Google Scholar 

  26. Kuch B, Schunkert H, Muscholl M, Doring A, von Scheidt W, Hense HW . Distribution, determinants and reference values of left ventricular parameters in the general population – results of the MONICA/KORA Echocardiography Studies. Gesundheitswesen 2005; 67 (Suppl 1): 68–73.

    Article  Google Scholar 

  27. Ganau A, Devereux RB, Roman RJ, de Simone G, Pickering TG, Saba PS et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–1558.

    Article  CAS  Google Scholar 

  28. Kuch B, Muscholl M, Döring A, Riegger G, Schunkert H, Hense HW . Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens 1998; 12: 685–691.

    Article  CAS  Google Scholar 

  29. Dumesnil JG, Gaudreault G, Honos GN, Kingma JG . Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol 1991; 68: 515–519.

    Article  CAS  Google Scholar 

  30. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and Its complications. Report of a WHO Consultation Part 1. Diagnosis and classification of diabetes mellitus. WHO: Geneva, 1999 pp 1–59.

  31. Heyden S, Bartel AG, Tabesh E, Cassel JC, Tyroler HA et al. Angina pectoris and the Rose questionnaire. Arch Intern Med 1971; 128: 961–964.

    Article  CAS  Google Scholar 

  32. Arauz-Pacheco C, Parrott MA, Raskin P . The treatment of hypertension in adult patients with diabetes. Diab Care 2002; 25: 134–147.

    Article  Google Scholar 

  33. Struthers AD, Morris AD . Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 2002; 359: 1430–1432.

    Article  Google Scholar 

  34. Holmang A, Yoshida N, Jennische E, Waldenstrom A, Bjorntorp P . The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats. Eur J Clin Invest 1996; 26: 973–978.

    Article  CAS  Google Scholar 

  35. Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S . Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90: 928–936.

    Article  CAS  Google Scholar 

  36. Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB . Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with Type 2 diabetes. Am J Med 2002; 112: 603–609.

    Article  CAS  Google Scholar 

  37. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–17.

    Article  CAS  Google Scholar 

  38. Mulè G, Nardi E, Cottone S, Andronico G, Federico MR, Piazza G et al. Relationships between ambulatory white coat effect and left ventricular mass in arterial hypertension. Am J Hypertens 2003; 16: 498–501.

    Article  Google Scholar 

  39. Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G et al. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Hypertension 2002; 39: 44–49.

    Article  Google Scholar 

  40. Kosmala W, Kucharski W, Przewlocka-Kosmala M, Mazurek W . Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am J Cardiol 2004; 94: 395–399.

    Article  Google Scholar 

  41. Fang ZY, Najos-Valencia O, Leano R, Marwick TH . Patients with early diabetic heart disease demonstrate a normal response to dobutamine. J Am Coll Cardiol 2003; 42: 446–453.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The KORA research platform was initiated and financed by the GSF – National Research Center for Environment and Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The Augsburg Diabetes Family Study was mainly financed by the GSF and additionally supported by funds from the German Research Foundation (DFG-FKZ: WI 621/8-1). We thank all members of the GSF Institute of Epidemiology and the field staff in Augsburg who were involved in the planning and conduct of the study. Finally, we express our appreciation to all study participants.

This work was supported by the German Research Foundation (DFG-FKZ: WI 621/8-1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B Kuch.

Additional information

Conflicts of interest: None

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuch, B., von Scheidt, W., Peter, W. et al. Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type II diabetes: The Augsburg Diabetes Family Study. J Hum Hypertens 20, 757–764 (2006). https://doi.org/10.1038/sj.jhh.1002062

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002062

Keywords

This article is cited by

Search

Quick links